FDA announced a new
Dietary Supplement Ingredient Advisory List
, a rapid-response tool designed to quickly alert the public when the FDA identifies ingredients that do not appear to be lawfully marketed in dietary supplements. The announcement came on the same day FDA sent
11 warning letters
to companies for products marketed as dietary supplements and labeled to contain DMHA or phenibut.
In a press release, FDA highlighted its reaffirmed commitment to strengthen the regulation and oversight of dietary supplements through traditional advisory and enforcement actions like warning letters and the new tools like the
. Ingredients are added to the List based on a preliminary assessment by the FDA. The List enables the FDA to communicate with the public while it completes a final determination regarding these ingredients. The List is not exhaustive and will be updated.
"Consumers may wish to avoid buying and using products marketed as dietary supplements containing ingredients on this List, and industry may wish to avoid making or selling products marketed as dietary supplements containing these ingredients," FDA stated in a press release.